Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions
Top Cited Papers
Open Access
- 1 August 2009
- journal article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 11 (3), 558-569
- https://doi.org/10.1208/s12248-009-9133-0
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric StudiesAntimicrobial Agents and Chemotherapy, 2009
- Mechanistic modelling of tesaglitazar pharmacokinetic data in subjects with various degrees of renal function – evidence of interconversionBritish Journal of Clinical Pharmacology, 2008
- Pharmacokinetics of Desmopressin Administrated as an Oral Lyophilisate Dosage Form in Children With Primary Nocturnal Enuresis and Healthy AdultsThe Journal of Clinical Pharmacology, 2006
- Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applicationsThe AAPS Journal, 2005
- Pharmacokinetic/pharmacodynamic models for the depletion of Vβ5.2/5.3 T cells by the monoclonal antibody ATM‐027 in patients with multiple sclerosis, as measured by FACSBritish Journal of Clinical Pharmacology, 2004
- Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of Pharmacokinetics and PharmacodynamicsBritish Journal of Clinical Pharmacology, 1997
- Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of Pharmacokinetics and PharmacodynamicsBritish Journal of Clinical Pharmacology, 1997
- The importance of modeling interoccasion variability in population pharmacokinetic analysesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: Application to pefloxacin in intensive care unit patientsJournal of Pharmacokinetics and Biopharmaceutics, 1992
- Building population pharmacokineticpharmacodynamic models. I. Models for covariate effectsJournal of Pharmacokinetics and Biopharmaceutics, 1992